We previously reported that 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced
Parkinson's disease (PD) model mice (PD mice) facilitate hippocampal memory extinction …

There is mounting evidence that the microbiota–gut–brain axis (MGBA) is critical in the
pathogenesis and progression of Parkinson's disease (PD), suggesting that probiotic …

It has previously been shown that the consumption of probiotics may have beneficial effects
not only on peripheral tissues but also on the central nervous system and behavior via the …

Probiotics improve brain function, including memory and cognition, via the microbiome–gut–
brain axis. Oral administration of Bifidobacterium breve MCC1274 (B. breve MCC1274) …

Parkinson's disease (PD) is a neurological disorder with motor dysfunction and a number of
psychiatric symptoms. Symptoms such as anxiety and cognitive deficits emerge prior to …

Intestinal dysbiosis plays a critical role in the pathogenesis of Parkinson's disease (PD), and
probiotics have emerged as potential modulators of central nervous system function through …

Human gut microbiota are thought to affect different physiological processes in the body,
including brain functions. Gut dysbiosis has been linked to the progression of Parkinson's …

Microbiota in the gut affect brain physiology via various pathways, and dysbiosis seems to
play a role in the pathogenesis of Parkinson's disease (PD). Probiotics showed pleiotropic …

Alzheimer's disease (AD) is a neurodegenerative disease, pathological markers of which
are amyloid plaques and neurofibrillary tangles. As a key node of gut–brain axis, gut …

Psychobiotics are used to treat neurological disorders, including mild cognitive impairment
(MCI) and Alzheimer's disease (AD). However, the mechanisms underlying their …